Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | $138.1M | $88.3M | $171.4M | $147.7M | $75.2M | $101.3M | $188.4M | $223.9M | $246.1M | $362.6M | $928.6M | $443.2M | $487.0M | $825.2M | $685.1M | $901.0M | $647.0M | $1,402.3M | $953.4M | $629.5M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Edwards Lifesciences Corporation's last 12-month Free Cash Flow is $502.2M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Edwards Lifesciences Corporation's Free Cash Flow growth was (36.3%). The average annual Free Cash Flow growth rates for Edwards Lifesciences Corporation have been (11.2%) over the past three years, (9.0%) over the past five years.
Over the last year, Edwards Lifesciences Corporation's Free Cash Flow growth was (36.3%), which is lower than industry growth of (0.2%). It indicates that Edwards Lifesciences Corporation's Free Cash Flow growth is Bad.